NO146096C - Analogifremgangsmaate ved fremstilling av thienothiazinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av thienothiazinderivater

Info

Publication number
NO146096C
NO146096C NO752932A NO752932A NO146096C NO 146096 C NO146096 C NO 146096C NO 752932 A NO752932 A NO 752932A NO 752932 A NO752932 A NO 752932A NO 146096 C NO146096 C NO 146096C
Authority
NO
Norway
Prior art keywords
preparation
analogy procedure
thienothiazine derivatives
thienothiazine
derivatives
Prior art date
Application number
NO752932A
Other languages
English (en)
Norwegian (no)
Other versions
NO146096B (no
NO752932L (OSRAM
Inventor
Otto Hromatka
Dieter Binder
Rudolf Pfister
Paul Zeller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1158274A external-priority patent/CH608500A5/de
Priority claimed from CH1215774A external-priority patent/CH608501A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO752932L publication Critical patent/NO752932L/no
Publication of NO146096B publication Critical patent/NO146096B/no
Publication of NO146096C publication Critical patent/NO146096C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Manufacturing Of Printed Wiring (AREA)
NO752932A 1974-08-26 1975-08-26 Analogifremgangsmaate ved fremstilling av thienothiazinderivater NO146096C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1158274A CH608500A5 (en) 1974-08-26 1974-08-26 Process for the preparation of thiazine derivatives
CH1215774A CH608501A5 (en) 1974-09-09 1974-09-09 Process for the preparation of thiazine derivatives

Publications (3)

Publication Number Publication Date
NO752932L NO752932L (OSRAM) 1976-02-27
NO146096B NO146096B (no) 1982-04-19
NO146096C true NO146096C (no) 1982-07-28

Family

ID=25708582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752932A NO146096C (no) 1974-08-26 1975-08-26 Analogifremgangsmaate ved fremstilling av thienothiazinderivater

Country Status (20)

Country Link
JP (1) JPS5826758B2 (OSRAM)
AR (1) AR216288A1 (OSRAM)
AT (1) AT350064B (OSRAM)
BR (1) BR7505463A (OSRAM)
DD (1) DD124119A5 (OSRAM)
DE (1) DE2537070A1 (OSRAM)
DK (1) DK137835B (OSRAM)
FI (1) FI59253C (OSRAM)
FR (3) FR2282893A1 (OSRAM)
GB (1) GB1519811A (OSRAM)
HU (1) HU173739B (OSRAM)
IE (1) IE41457B1 (OSRAM)
IL (1) IL47877A (OSRAM)
LU (2) LU73257A1 (OSRAM)
NL (2) NL183582C (OSRAM)
NO (1) NO146096C (OSRAM)
PL (1) PL106076B1 (OSRAM)
SE (1) SE412066B (OSRAM)
SU (1) SU603338A3 (OSRAM)
YU (1) YU40266B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704485A1 (de) * 1977-02-03 1978-08-10 Thomae Gmbh Dr K Neue 2,5-dihydro-1,2-thiazino eckige klammer auf 5,6-b eckige klammer zu indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
LU78009A1 (de) 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
ZA784958B (en) * 1977-09-06 1979-08-29 Hoffmann La Roche Thiazine derivatives
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
JPS58109492A (ja) * 1981-12-22 1983-06-29 Mitsui Toatsu Chem Inc チエノチアジン誘導体およびそれを含有する医薬組成物
DE3371082D1 (de) * 1982-09-09 1987-05-27 Hoffmann La Roche Thieno(2,3-e)-1,2-thiazine derivatives
ATA39088A (de) 1988-02-18 1990-06-15 Binder Dieter Dr Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
AT400437B (de) * 1993-12-14 1995-12-27 Chem Pharm Forsch Gmbh Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
AT400568B (de) * 1994-05-18 1996-01-25 Chem Pharm Forsch Gmbh Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
US5538966A (en) * 1994-01-21 1996-07-23 Alcon Laboratories, Inc. Carbonic anhydrase inhibitors
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
CN1171892C (zh) * 2001-06-25 2004-10-20 李晶 具有抗炎镇痛活性的噻吩并噻嗪化合物及其制备方法和用途

Also Published As

Publication number Publication date
IE41457B1 (en) 1980-01-02
AT350064B (de) 1979-05-10
DE2537070A1 (de) 1976-03-18
FR2303803A1 (fr) 1976-10-08
FR2282893A1 (fr) 1976-03-26
LU73257A1 (OSRAM) 1977-04-15
JPS5826758B2 (ja) 1983-06-04
NL930080I2 (nl) 1994-01-03
YU216675A (en) 1982-08-31
DE2537070C2 (OSRAM) 1987-06-25
AR216288A1 (es) 1979-12-14
NL183582C (nl) 1988-12-01
LU88312I2 (de) 1994-09-09
NL7510057A (nl) 1976-03-01
NL930080I1 (nl) 1993-09-16
IL47877A (en) 1978-10-31
ATA655975A (de) 1978-10-15
FI59253B (fi) 1981-03-31
NO146096B (no) 1982-04-19
FR2309558B1 (OSRAM) 1979-05-04
DK137835B (da) 1978-05-16
NO752932L (OSRAM) 1976-02-27
FI752398A7 (OSRAM) 1976-02-27
GB1519811A (en) 1978-08-02
SE7509446L (sv) 1976-02-27
IL47877A0 (en) 1975-11-25
HU173739B (hu) 1979-08-28
NL183582B (nl) 1988-07-01
DK381175A (OSRAM) 1976-02-27
AU8418675A (en) 1977-02-24
JPS5148694A (OSRAM) 1976-04-26
YU40266B (en) 1985-12-31
PL106076B1 (pl) 1979-11-30
DD124119A5 (OSRAM) 1977-02-02
IE41457L (en) 1976-02-26
SE412066B (sv) 1980-02-18
FR2303803B1 (OSRAM) 1979-07-13
FR2309558A1 (fr) 1976-11-26
DK137835C (OSRAM) 1978-10-16
BR7505463A (pt) 1976-08-03
FR2282893B1 (OSRAM) 1980-05-16
SU603338A3 (ru) 1978-04-15
FI59253C (fi) 1981-07-10

Similar Documents

Publication Publication Date Title
SE7513085L (sv) Forfarande for framstellning av etrar
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO144111C (no) Fremgangsmaate ved fremstilling av immunoglobulinderivater
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
DK143902C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO140297C (no) Fremgangsmaate ved fremstilling av alfa1-t-butylaminomethyl-4-hydroxy-m-xylen-alfa1,alfa3-diol
NO143224C (no) Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner
NO141514C (no) Fremgangsmaate ved fremstilling av aluminiumsalter av n-nitroso-n-alkyl-hydroksylaminer